|
'Pathway Search Results'
- Selection criteria for significant gene list :
-
Significant genes are selected with a p value cut-off of 0.1. The resultant list was then sorted in a descending order of fold change value. From the sorted list, the top 100 genes were selected for pathway/network. If the gene list is less than 100, the entire gene list was taken for pathway/network analysis.
|
>>Total hits : 2
, Search term given : Cystic AND Fibrosis
|
Cystic fibrosis patients with mild and severe lung disease: nasal respiratory epithelium (HG-U133A)
|
GEO Description :
Analysis of the nasal respiratory epithelium of cystic fibrosis (CF) patients with mild or severe lung disease. CF patients have identical homozygous deltaF508 CFTR genotypes but exhibit variability in pulmonary disease severity. Results provide insight into the basis of the phenotypic difference.
Organism : Homo sapiens
GEO-ID : GDS2142
|
|
|
- Compared Group :
- normal Vs severe cystic fibrosis
|
- Number of Nodes in the Network : 18
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 0.00124305335339159
- Fold Change Cut-Off : 2.72
|
|
|
- Compared Group :
- normal Vs mild cystic fibrosis
|
- Number of Nodes in the Network : 43
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 0.000363800121704116
- Fold Change Cut-Off : 2.06
|
DISCLAIMER:
The interactions, networks, list of genes/molecules or any other information presented here, is HYPOTHETICAL in nature and is based on information collected from public as well as other sources, and is analyzed by certain automated mining and analysis software workflows. Strandlife Science Pvt.Ltd. or the Editors of PathwayWorld offer this information with NO CLAIMS of accuracy and WARRANTIES of any kind, and DO NOT Accept liability or legal responsibility for losses allegedly caused by using this information.
GeneSpring® is a registered trademark of Agilent Technologies.
GeneSpring® is developed on AVADIS™ from Strand Life Sciences
|
